(19)
(11) EP 2 296 700 A2

(12)

(88) Date of publication A3:
15.07.2010

(43) Date of publication:
23.03.2011 Bulletin 2011/12

(21) Application number: 09820933.1

(22) Date of filing: 03.06.2009
(51) International Patent Classification (IPC): 
A61K 39/12(2006.01)
A61K 39/145(2006.01)
 A61K 39/235(2006.01)
(86) International application number:
PCT/US2009/046132
(87) International publication number:
WO 2010/044921 (22.04.2010 Gazette 2010/16)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA RS

(30) Priority: 03.06.2008 US 58413 P

(71) Applicant: Vaxin, Inc.
Birmingham, AL 35203 (US)

(72) Inventors:
  • TANG, De-chu, C.
    Hoover AL 35244 (US)
  • VAN KAMPEN, Kent, R.
    Birmingham AL 35203 (US)

(74) Representative: Bühler, Dirk 
Maiwald Patentanwalts GmbH Elisenhof Elisenstraße 3
80335 München
80335 München (DE)

   


(54) INTRANASAL ADMINISTRATION OF RECEPTOR-BINDING LIGANDS OR GENES ENCODING SUCH LIGANDS AS A THERAPEUTIC REGIMEN FOR MITIGATING INFECTIONS CAUSED BY RESPIRATORY PATHOGENS